article thumbnail

DASH Diet for Diabetes With Low Sodium Reduces BP in Those With Diabetes

Physician's Weekly

WEDNESDAY, June 18, 2025 (HealthDay News) — The Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet with lower sodium is tied to clinically meaningful blood pressure reduction in people with diabetes, according to a study published online June 9 in JAMA Internal Medicine. Pilla, M.D.,

article thumbnail

Diabetes drugs associated with fewer adverse cardiac events in older veterans

Medical Xpress

GLP1 receptor agonists—a class of diabetes medications—are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Episode 242: WDx #17 – “The Next Play”

The Clinical Problem Solvers

Uttara (Tara) Gadde Uttara (Tara) Gadde is an internal medicine resident at the University of Pennsylvania. Aimee K Zaas Aimee K Zaas MD MHS is a Professor of Medicine in the Division of Infectious Diseases in the Department of Medicine at Duke University School of Medicine. in Human Biology, Health & Society.

article thumbnail

Wakefulness-promoting agents effective for excessive daytime sleepiness but patients may discontinue due to side effects

Medical Xpress

However, patients may be more likely to discontinue the use of these medications due to adverse events including headache, anxiety, and insomnia. The review is published in Annals of Internal Medicine.

article thumbnail

Geriatric Medicine Board Meeting Summary | Spring 2025

ABIM

McDonald shared more about a pilot model announced last year that would create a pathway for exceptionally qualified international medical graduates (IMGs) successfully completing ACGME-accredited subspecialty fellowship to become Board eligible in Internal Medicine and subspecialties.

article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Physician's Weekly

The FDA approval is based on positive results from two international phase 3 trials that compared Widaplik to dual combinations of its component drugs as well as to placebo. The most common adverse event reported in patients treated with Widaplik was symptomatic low blood pressure.

article thumbnail

Tech upgrade success: 6 rules every practice should follow

Physician's Practice

Reynolds Fact checked by Chris Mazzolini Blog Article Navigating the health tech landscape requires strategic diligence to avoid hidden costs and ensure seamless integration in medical practices.